Global Human Vaccine Adjuvants Supply, Demand and Key Producers, 2024-2030

Page: 111

Published Date: 01 Apr 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global Human Vaccine Adjuvants market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

In China, the key players of human vaccine adjuvants include GSK, CSL Limited, Croda, SEPPIC, Sanofi, Zhifei Biological, etc.

This report studies the global Human Vaccine Adjuvants production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Human Vaccine Adjuvants, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Human Vaccine Adjuvants that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Human Vaccine Adjuvants total production and demand, 2019-2030, (Tons)
Global Human Vaccine Adjuvants total production value, 2019-2030, (USD Million)
Global Human Vaccine Adjuvants production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (Tons)
Global Human Vaccine Adjuvants consumption by region & country, CAGR, 2019-2030 & (Tons)
U.S. VS China: Human Vaccine Adjuvants domestic production, consumption, key domestic manufacturers and share
Global Human Vaccine Adjuvants production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (Tons)
Global Human Vaccine Adjuvants production by Type, production, value, CAGR, 2019-2030, (USD Million) & (Tons)
Global Human Vaccine Adjuvants production by Application production, value, CAGR, 2019-2030, (USD Million) & (Tons).

This reports profiles key players in the global Human Vaccine Adjuvants market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GSK, CSL Limited, Croda, SEPPIC, Sanofi, Zhifei Biological, Escon, Huanuotai Biological and Rico Bio, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Human Vaccine Adjuvants market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Tons) and average price (US$/吨) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Human Vaccine Adjuvants Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Human Vaccine Adjuvants Market, Segmentation by Type
    Aluminium Salt Adjuvant
    Oil Emulsion Adjuvant
    Others

Global Human Vaccine Adjuvants Market, Segmentation by Application
    Commercial
    Research

Companies Profiled:
    GSK
    CSL Limited
    Croda
    SEPPIC
    Sanofi
    Zhifei Biological
    Escon
    Huanuotai Biological
    Rico Bio

Key Questions Answered
1. How big is the global Human Vaccine Adjuvants market?
2. What is the demand of the global Human Vaccine Adjuvants market?
3. What is the year over year growth of the global Human Vaccine Adjuvants market?
4. What is the production and production value of the global Human Vaccine Adjuvants market?
5. Who are the key producers in the global Human Vaccine Adjuvants market?

Table of Contents

1 Supply Summary
    1.1 Human Vaccine Adjuvants Introduction
    1.2 World Human Vaccine Adjuvants Supply & Forecast
        1.2.1 World Human Vaccine Adjuvants Production Value (2019 & 2023 & 2030)
        1.2.2 World Human Vaccine Adjuvants Production (2019-2030)
        1.2.3 World Human Vaccine Adjuvants Pricing Trends (2019-2030)
    1.3 World Human Vaccine Adjuvants Production by Region (Based on Production Site)
        1.3.1 World Human Vaccine Adjuvants Production Value by Region (2019-2030)
        1.3.2 World Human Vaccine Adjuvants Production by Region (2019-2030)
        1.3.3 World Human Vaccine Adjuvants Average Price by Region (2019-2030)
        1.3.4 Australia Human Vaccine Adjuvants Production (2019-2030)
        1.3.5 Europe Human Vaccine Adjuvants Production (2019-2030)
        1.3.6 China Human Vaccine Adjuvants Production (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Human Vaccine Adjuvants Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Human Vaccine Adjuvants Major Market Trends

2 Demand Summary
    2.1 World Human Vaccine Adjuvants Demand (2019-2030)
    2.2 World Human Vaccine Adjuvants Consumption by Region
        2.2.1 World Human Vaccine Adjuvants Consumption by Region (2019-2024)
        2.2.2 World Human Vaccine Adjuvants Consumption Forecast by Region (2025-2030)
    2.3 United States Human Vaccine Adjuvants Consumption (2019-2030)
    2.4 China Human Vaccine Adjuvants Consumption (2019-2030)
    2.5 Europe Human Vaccine Adjuvants Consumption (2019-2030)
    2.6 Japan Human Vaccine Adjuvants Consumption (2019-2030)
    2.7 South Korea Human Vaccine Adjuvants Consumption (2019-2030)
    2.8 ASEAN Human Vaccine Adjuvants Consumption (2019-2030)
    2.9 India Human Vaccine Adjuvants Consumption (2019-2030)

3 World Human Vaccine Adjuvants Manufacturers Competitive Analysis
    3.1 World Human Vaccine Adjuvants Production Value by Manufacturer (2019-2024)
    3.2 World Human Vaccine Adjuvants Production by Manufacturer (2019-2024)
    3.3 World Human Vaccine Adjuvants Average Price by Manufacturer (2019-2024)
    3.4 Human Vaccine Adjuvants Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Human Vaccine Adjuvants Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Human Vaccine Adjuvants in 2023
        3.5.3 Global Concentration Ratios (CR8) for Human Vaccine Adjuvants in 2023
    3.6 Human Vaccine Adjuvants Market: Overall Company Footprint Analysis
        3.6.1 Human Vaccine Adjuvants Market: Region Footprint
        3.6.2 Human Vaccine Adjuvants Market: Company Product Type Footprint
        3.6.3 Human Vaccine Adjuvants Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Human Vaccine Adjuvants Production Value Comparison
        4.1.1 United States VS China: Human Vaccine Adjuvants Production Value Comparison (2019 & 2023 & 2030)
        4.1.2 United States VS China: Human Vaccine Adjuvants Production Value Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States VS China: Human Vaccine Adjuvants Production Comparison
        4.2.1 United States VS China: Human Vaccine Adjuvants Production Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Human Vaccine Adjuvants Production Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States VS China: Human Vaccine Adjuvants Consumption Comparison
        4.3.1 United States VS China: Human Vaccine Adjuvants Consumption Comparison (2019 & 2023 & 2030)
        4.3.2 United States VS China: Human Vaccine Adjuvants Consumption Market Share Comparison (2019 & 2023 & 2030)
    4.4 United States Based Human Vaccine Adjuvants Manufacturers and Market Share, 2019-2024
        4.4.1 United States Based Human Vaccine Adjuvants Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Human Vaccine Adjuvants Production Value (2019-2024)
        4.4.3 United States Based Manufacturers Human Vaccine Adjuvants Production (2019-2024)
    4.5 China Based Human Vaccine Adjuvants Manufacturers and Market Share
        4.5.1 China Based Human Vaccine Adjuvants Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Human Vaccine Adjuvants Production Value (2019-2024)
        4.5.3 China Based Manufacturers Human Vaccine Adjuvants Production (2019-2024)
    4.6 Rest of World Based Human Vaccine Adjuvants Manufacturers and Market Share, 2019-2024
        4.6.1 Rest of World Based Human Vaccine Adjuvants Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Human Vaccine Adjuvants Production Value (2019-2024)
        4.6.3 Rest of World Based Manufacturers Human Vaccine Adjuvants Production (2019-2024)

5 Market Analysis by Type
    5.1 World Human Vaccine Adjuvants Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Aluminium Salt Adjuvant
        5.2.2 Oil Emulsion Adjuvant
        5.2.3 Others
    5.3 Market Segment by Type
        5.3.1 World Human Vaccine Adjuvants Production by Type (2019-2030)
        5.3.2 World Human Vaccine Adjuvants Production Value by Type (2019-2030)
        5.3.3 World Human Vaccine Adjuvants Average Price by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Human Vaccine Adjuvants Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Commercial
        6.2.2 Research
    6.3 Market Segment by Application
        6.3.1 World Human Vaccine Adjuvants Production by Application (2019-2030)
        6.3.2 World Human Vaccine Adjuvants Production Value by Application (2019-2030)
        6.3.3 World Human Vaccine Adjuvants Average Price by Application (2019-2030)

7 Company Profiles
    7.1 GSK
        7.1.1 GSK Details
        7.1.2 GSK Major Business
        7.1.3 GSK Human Vaccine Adjuvants Product and Services
        7.1.4 GSK Human Vaccine Adjuvants Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.1.5 GSK Recent Developments/Updates
        7.1.6 GSK Competitive Strengths & Weaknesses
    7.2 CSL Limited
        7.2.1 CSL Limited Details
        7.2.2 CSL Limited Major Business
        7.2.3 CSL Limited Human Vaccine Adjuvants Product and Services
        7.2.4 CSL Limited Human Vaccine Adjuvants Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.2.5 CSL Limited Recent Developments/Updates
        7.2.6 CSL Limited Competitive Strengths & Weaknesses
    7.3 Croda
        7.3.1 Croda Details
        7.3.2 Croda Major Business
        7.3.3 Croda Human Vaccine Adjuvants Product and Services
        7.3.4 Croda Human Vaccine Adjuvants Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.3.5 Croda Recent Developments/Updates
        7.3.6 Croda Competitive Strengths & Weaknesses
    7.4 SEPPIC
        7.4.1 SEPPIC Details
        7.4.2 SEPPIC Major Business
        7.4.3 SEPPIC Human Vaccine Adjuvants Product and Services
        7.4.4 SEPPIC Human Vaccine Adjuvants Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.4.5 SEPPIC Recent Developments/Updates
        7.4.6 SEPPIC Competitive Strengths & Weaknesses
    7.5 Sanofi
        7.5.1 Sanofi Details
        7.5.2 Sanofi Major Business
        7.5.3 Sanofi Human Vaccine Adjuvants Product and Services
        7.5.4 Sanofi Human Vaccine Adjuvants Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.5.5 Sanofi Recent Developments/Updates
        7.5.6 Sanofi Competitive Strengths & Weaknesses
    7.6 Zhifei Biological
        7.6.1 Zhifei Biological Details
        7.6.2 Zhifei Biological Major Business
        7.6.3 Zhifei Biological Human Vaccine Adjuvants Product and Services
        7.6.4 Zhifei Biological Human Vaccine Adjuvants Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.6.5 Zhifei Biological Recent Developments/Updates
        7.6.6 Zhifei Biological Competitive Strengths & Weaknesses
    7.7 Escon
        7.7.1 Escon Details
        7.7.2 Escon Major Business
        7.7.3 Escon Human Vaccine Adjuvants Product and Services
        7.7.4 Escon Human Vaccine Adjuvants Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.7.5 Escon Recent Developments/Updates
        7.7.6 Escon Competitive Strengths & Weaknesses
    7.8 Huanuotai Biological
        7.8.1 Huanuotai Biological Details
        7.8.2 Huanuotai Biological Major Business
        7.8.3 Huanuotai Biological Human Vaccine Adjuvants Product and Services
        7.8.4 Huanuotai Biological Human Vaccine Adjuvants Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.8.5 Huanuotai Biological Recent Developments/Updates
        7.8.6 Huanuotai Biological Competitive Strengths & Weaknesses
    7.9 Rico Bio
        7.9.1 Rico Bio Details
        7.9.2 Rico Bio Major Business
        7.9.3 Rico Bio Human Vaccine Adjuvants Product and Services
        7.9.4 Rico Bio Human Vaccine Adjuvants Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.9.5 Rico Bio Recent Developments/Updates
        7.9.6 Rico Bio Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Human Vaccine Adjuvants Industry Chain
    8.2 Human Vaccine Adjuvants Upstream Analysis
        8.2.1 Human Vaccine Adjuvants Core Raw Materials
        8.2.2 Main Manufacturers of Human Vaccine Adjuvants Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Human Vaccine Adjuvants Production Mode
    8.6 Human Vaccine Adjuvants Procurement Model
    8.7 Human Vaccine Adjuvants Industry Sales Model and Sales Channels
        8.7.1 Human Vaccine Adjuvants Sales Model
        8.7.2 Human Vaccine Adjuvants Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Human Vaccine Adjuvants Production Value by Region (2019, 2023 and 2030) & (USD Million)
    Table 2. World Human Vaccine Adjuvants Production Value by Region (2019-2024) & (USD Million)
    Table 3. World Human Vaccine Adjuvants Production Value by Region (2025-2030) & (USD Million)
    Table 4. World Human Vaccine Adjuvants Production Value Market Share by Region (2019-2024)
    Table 5. World Human Vaccine Adjuvants Production Value Market Share by Region (2025-2030)
    Table 6. World Human Vaccine Adjuvants Production by Region (2019-2024) & (Tons)
    Table 7. World Human Vaccine Adjuvants Production by Region (2025-2030) & (Tons)
    Table 8. World Human Vaccine Adjuvants Production Market Share by Region (2019-2024)
    Table 9. World Human Vaccine Adjuvants Production Market Share by Region (2025-2030)
    Table 10. World Human Vaccine Adjuvants Average Price by Region (2019-2024) & (US$/吨)
    Table 11. World Human Vaccine Adjuvants Average Price by Region (2025-2030) & (US$/吨)
    Table 12. Human Vaccine Adjuvants Major Market Trends
    Table 13. World Human Vaccine Adjuvants Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (Tons)
    Table 14. World Human Vaccine Adjuvants Consumption by Region (2019-2024) & (Tons)
    Table 15. World Human Vaccine Adjuvants Consumption Forecast by Region (2025-2030) & (Tons)
    Table 16. World Human Vaccine Adjuvants Production Value by Manufacturer (2019-2024) & (USD Million)
    Table 17. Production Value Market Share of Key Human Vaccine Adjuvants Producers in 2023
    Table 18. World Human Vaccine Adjuvants Production by Manufacturer (2019-2024) & (Tons)
    Table 19. Production Market Share of Key Human Vaccine Adjuvants Producers in 2023
    Table 20. World Human Vaccine Adjuvants Average Price by Manufacturer (2019-2024) & (US$/吨)
    Table 21. Global Human Vaccine Adjuvants Company Evaluation Quadrant
    Table 22. World Human Vaccine Adjuvants Industry Rank of Major Manufacturers, Based on Production Value in 2023
    Table 23. Head Office and Human Vaccine Adjuvants Production Site of Key Manufacturer
    Table 24. Human Vaccine Adjuvants Market: Company Product Type Footprint
    Table 25. Human Vaccine Adjuvants Market: Company Product Application Footprint
    Table 26. Human Vaccine Adjuvants Competitive Factors
    Table 27. Human Vaccine Adjuvants New Entrant and Capacity Expansion Plans
    Table 28. Human Vaccine Adjuvants Mergers & Acquisitions Activity
    Table 29. United States VS China Human Vaccine Adjuvants Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 30. United States VS China Human Vaccine Adjuvants Production Comparison, (2019 & 2023 & 2030) & (Tons)
    Table 31. United States VS China Human Vaccine Adjuvants Consumption Comparison, (2019 & 2023 & 2030) & (Tons)
    Table 32. United States Based Human Vaccine Adjuvants Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Human Vaccine Adjuvants Production Value, (2019-2024) & (USD Million)
    Table 34. United States Based Manufacturers Human Vaccine Adjuvants Production Value Market Share (2019-2024)
    Table 35. United States Based Manufacturers Human Vaccine Adjuvants Production (2019-2024) & (Tons)
    Table 36. United States Based Manufacturers Human Vaccine Adjuvants Production Market Share (2019-2024)
    Table 37. China Based Human Vaccine Adjuvants Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Human Vaccine Adjuvants Production Value, (2019-2024) & (USD Million)
    Table 39. China Based Manufacturers Human Vaccine Adjuvants Production Value Market Share (2019-2024)
    Table 40. China Based Manufacturers Human Vaccine Adjuvants Production (2019-2024) & (Tons)
    Table 41. China Based Manufacturers Human Vaccine Adjuvants Production Market Share (2019-2024)
    Table 42. Rest of World Based Human Vaccine Adjuvants Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Human Vaccine Adjuvants Production Value, (2019-2024) & (USD Million)
    Table 44. Rest of World Based Manufacturers Human Vaccine Adjuvants Production Value Market Share (2019-2024)
    Table 45. Rest of World Based Manufacturers Human Vaccine Adjuvants Production (2019-2024) & (Tons)
    Table 46. Rest of World Based Manufacturers Human Vaccine Adjuvants Production Market Share (2019-2024)
    Table 47. World Human Vaccine Adjuvants Production Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 48. World Human Vaccine Adjuvants Production by Type (2019-2024) & (Tons)
    Table 49. World Human Vaccine Adjuvants Production by Type (2025-2030) & (Tons)
    Table 50. World Human Vaccine Adjuvants Production Value by Type (2019-2024) & (USD Million)
    Table 51. World Human Vaccine Adjuvants Production Value by Type (2025-2030) & (USD Million)
    Table 52. World Human Vaccine Adjuvants Average Price by Type (2019-2024) & (US$/吨)
    Table 53. World Human Vaccine Adjuvants Average Price by Type (2025-2030) & (US$/吨)
    Table 54. World Human Vaccine Adjuvants Production Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 55. World Human Vaccine Adjuvants Production by Application (2019-2024) & (Tons)
    Table 56. World Human Vaccine Adjuvants Production by Application (2025-2030) & (Tons)
    Table 57. World Human Vaccine Adjuvants Production Value by Application (2019-2024) & (USD Million)
    Table 58. World Human Vaccine Adjuvants Production Value by Application (2025-2030) & (USD Million)
    Table 59. World Human Vaccine Adjuvants Average Price by Application (2019-2024) & (US$/吨)
    Table 60. World Human Vaccine Adjuvants Average Price by Application (2025-2030) & (US$/吨)
    Table 61. GSK Basic Information, Manufacturing Base and Competitors
    Table 62. GSK Major Business
    Table 63. GSK Human Vaccine Adjuvants Product and Services
    Table 64. GSK Human Vaccine Adjuvants Production (Tons), Price (US$/吨), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 65. GSK Recent Developments/Updates
    Table 66. GSK Competitive Strengths & Weaknesses
    Table 67. CSL Limited Basic Information, Manufacturing Base and Competitors
    Table 68. CSL Limited Major Business
    Table 69. CSL Limited Human Vaccine Adjuvants Product and Services
    Table 70. CSL Limited Human Vaccine Adjuvants Production (Tons), Price (US$/吨), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 71. CSL Limited Recent Developments/Updates
    Table 72. CSL Limited Competitive Strengths & Weaknesses
    Table 73. Croda Basic Information, Manufacturing Base and Competitors
    Table 74. Croda Major Business
    Table 75. Croda Human Vaccine Adjuvants Product and Services
    Table 76. Croda Human Vaccine Adjuvants Production (Tons), Price (US$/吨), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 77. Croda Recent Developments/Updates
    Table 78. Croda Competitive Strengths & Weaknesses
    Table 79. SEPPIC Basic Information, Manufacturing Base and Competitors
    Table 80. SEPPIC Major Business
    Table 81. SEPPIC Human Vaccine Adjuvants Product and Services
    Table 82. SEPPIC Human Vaccine Adjuvants Production (Tons), Price (US$/吨), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 83. SEPPIC Recent Developments/Updates
    Table 84. SEPPIC Competitive Strengths & Weaknesses
    Table 85. Sanofi Basic Information, Manufacturing Base and Competitors
    Table 86. Sanofi Major Business
    Table 87. Sanofi Human Vaccine Adjuvants Product and Services
    Table 88. Sanofi Human Vaccine Adjuvants Production (Tons), Price (US$/吨), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 89. Sanofi Recent Developments/Updates
    Table 90. Sanofi Competitive Strengths & Weaknesses
    Table 91. Zhifei Biological Basic Information, Manufacturing Base and Competitors
    Table 92. Zhifei Biological Major Business
    Table 93. Zhifei Biological Human Vaccine Adjuvants Product and Services
    Table 94. Zhifei Biological Human Vaccine Adjuvants Production (Tons), Price (US$/吨), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 95. Zhifei Biological Recent Developments/Updates
    Table 96. Zhifei Biological Competitive Strengths & Weaknesses
    Table 97. Escon Basic Information, Manufacturing Base and Competitors
    Table 98. Escon Major Business
    Table 99. Escon Human Vaccine Adjuvants Product and Services
    Table 100. Escon Human Vaccine Adjuvants Production (Tons), Price (US$/吨), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 101. Escon Recent Developments/Updates
    Table 102. Escon Competitive Strengths & Weaknesses
    Table 103. Huanuotai Biological Basic Information, Manufacturing Base and Competitors
    Table 104. Huanuotai Biological Major Business
    Table 105. Huanuotai Biological Human Vaccine Adjuvants Product and Services
    Table 106. Huanuotai Biological Human Vaccine Adjuvants Production (Tons), Price (US$/吨), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 107. Huanuotai Biological Recent Developments/Updates
    Table 108. Rico Bio Basic Information, Manufacturing Base and Competitors
    Table 109. Rico Bio Major Business
    Table 110. Rico Bio Human Vaccine Adjuvants Product and Services
    Table 111. Rico Bio Human Vaccine Adjuvants Production (Tons), Price (US$/吨), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 112. Global Key Players of Human Vaccine Adjuvants Upstream (Raw Materials)
    Table 113. Human Vaccine Adjuvants Typical Customers
    Table 114. Human Vaccine Adjuvants Typical Distributors
List of Figure
    Figure 1. Human Vaccine Adjuvants Picture
    Figure 2. World Human Vaccine Adjuvants Production Value: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World Human Vaccine Adjuvants Production Value and Forecast (2019-2030) & (USD Million)
    Figure 4. World Human Vaccine Adjuvants Production (2019-2030) & (Tons)
    Figure 5. World Human Vaccine Adjuvants Average Price (2019-2030) & (US$/吨)
    Figure 6. World Human Vaccine Adjuvants Production Value Market Share by Region (2019-2030)
    Figure 7. World Human Vaccine Adjuvants Production Market Share by Region (2019-2030)
    Figure 8. Australia Human Vaccine Adjuvants Production (2019-2030) & (Tons)
    Figure 9. Europe Human Vaccine Adjuvants Production (2019-2030) & (Tons)
    Figure 10. China Human Vaccine Adjuvants Production (2019-2030) & (Tons)
    Figure 11. Human Vaccine Adjuvants Market Drivers
    Figure 12. Factors Affecting Demand
    Figure 13. World Human Vaccine Adjuvants Consumption (2019-2030) & (Tons)
    Figure 14. World Human Vaccine Adjuvants Consumption Market Share by Region (2019-2030)
    Figure 15. United States Human Vaccine Adjuvants Consumption (2019-2030) & (Tons)
    Figure 16. China Human Vaccine Adjuvants Consumption (2019-2030) & (Tons)
    Figure 17. Europe Human Vaccine Adjuvants Consumption (2019-2030) & (Tons)
    Figure 18. Japan Human Vaccine Adjuvants Consumption (2019-2030) & (Tons)
    Figure 19. South Korea Human Vaccine Adjuvants Consumption (2019-2030) & (Tons)
    Figure 20. ASEAN Human Vaccine Adjuvants Consumption (2019-2030) & (Tons)
    Figure 21. India Human Vaccine Adjuvants Consumption (2019-2030) & (Tons)
    Figure 22. Producer Shipments of Human Vaccine Adjuvants by Manufacturer Revenue ($MM) and Market Share (%): 2023
    Figure 23. Global Four-firm Concentration Ratios (CR4) for Human Vaccine Adjuvants Markets in 2023
    Figure 24. Global Four-firm Concentration Ratios (CR8) for Human Vaccine Adjuvants Markets in 2023
    Figure 25. United States VS China: Human Vaccine Adjuvants Production Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 26. United States VS China: Human Vaccine Adjuvants Production Market Share Comparison (2019 & 2023 & 2030)
    Figure 27. United States VS China: Human Vaccine Adjuvants Consumption Market Share Comparison (2019 & 2023 & 2030)
    Figure 28. United States Based Manufacturers Human Vaccine Adjuvants Production Market Share 2023
    Figure 29. China Based Manufacturers Human Vaccine Adjuvants Production Market Share 2023
    Figure 30. Rest of World Based Manufacturers Human Vaccine Adjuvants Production Market Share 2023
    Figure 31. World Human Vaccine Adjuvants Production Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 32. World Human Vaccine Adjuvants Production Value Market Share by Type in 2023
    Figure 33. Aluminium Salt Adjuvant
    Figure 34. Oil Emulsion Adjuvant
    Figure 35. Others
    Figure 36. World Human Vaccine Adjuvants Production Market Share by Type (2019-2030)
    Figure 37. World Human Vaccine Adjuvants Production Value Market Share by Type (2019-2030)
    Figure 38. World Human Vaccine Adjuvants Average Price by Type (2019-2030) & (US$/吨)
    Figure 39. World Human Vaccine Adjuvants Production Value by Application, (USD Million), 2019 & 2023 & 2030
    Figure 40. World Human Vaccine Adjuvants Production Value Market Share by Application in 2023
    Figure 41. Commercial
    Figure 42. Research
    Figure 43. World Human Vaccine Adjuvants Production Market Share by Application (2019-2030)
    Figure 44. World Human Vaccine Adjuvants Production Value Market Share by Application (2019-2030)
    Figure 45. World Human Vaccine Adjuvants Average Price by Application (2019-2030) & (US$/吨)
    Figure 46. Human Vaccine Adjuvants Industry Chain
    Figure 47. Human Vaccine Adjuvants Procurement Model
    Figure 48. Human Vaccine Adjuvants Sales Model
    Figure 49. Human Vaccine Adjuvants Sales Channels, Direct Sales, and Distribution
    Figure 50. Methodology
    Figure 51. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

GSK
CSL Limited
Croda
SEPPIC
Sanofi
Zhifei Biological
Escon
Huanuotai Biological
Rico Bio

Related Reports

Global Human Vaccine Adjuvants Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Human Vaccine Adjuvants Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 18 Mar 2023

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Human Vaccine Adjuvants market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Global Human Vaccine Adjuvants Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Human Vaccine Adjuvants Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Human Vaccine Adjuvants market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Product Tags

Human Vaccine Adjuvants

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>